Drug-Drug Interactions
• Anti-diabetics: Co-administration with insulin or other hypoglycaemic agents may increase the risk of hypoglycaemia.
• Diuretics: When combined with diuretics, there is an elevated risk of heart failure.
• Cationic Medicines: These medicines may inhibit metformin clearance, increasing its plasma concentration.
• CYP2C8 Inducers: Such agents can diminish the concentration of pioglitazone in the system, reducing efficacy.
Drug-Food Interactions
• High-fat Meals: The absorption of glimepiride can be delayed by the ingestion of fatty foods, impacting glycaemic control.
Drug-Disease Interactions
• Heart Disease: Pioglitazone may exacerbate heart failure, necessitating caution in patients with existing cardiac conditions.
• Lactic Acidosis: The use of metformin may lead to lactic acidosis, particularly in individuals with renal or severe hepatic disease.
• Diabetes: This tablet is not recommended for type 1 diabetes or diabetic ketoacidosis management.
• Bladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; consult your doctor if you have a history of this malignancy.